Hotline update of clinical trials and registries presented at the German Cardiac Society Meeting 2009

Abstract

This review article gives an overview on a number of novel clinical trials and registries in the field of cardiovascular medicine. Key presentations made at the 75th annual meeting of the German Cardiac Society, held in Mannheim, Germany, in April 2009 are reported. The data were presented by leading experts in the field with relevant positions in the trials and registries. These comprehensive summaries should provide the readers with the most recent data on diagnostic and therapeutic developments in cardiovascular medicine similar as previously reported (Rosenkranz et al. in Clin Res Cardiol 96:457-468, 9; Maier et al. in Clin Res Cardiol 97:356-363, 3).

Fig. 1

The most often used reason to perform a CMR imaging

Fig. 2

TIMI risk scores in patients included in FITT-STEMI

Fig. 3

Decrease in hospital mortality in STEMI (a) and STEMI complicated by cardiogenic shock (b)

Fig. 4

Persistent lipid disorders with ongoing statin therapy in correlation with the risk of cardiovascular complications

Fig. 5

Rates of outcomes among the study patients, according to treatment group [10]. Kaplan–Meier curves are shown for the percutaneous coronary intervention (PCI) group and the coronary-artery bypass grafting (CABG) group for death from any cause (Panel A); death, stroke, or myocardial infarction (MI) (Panel B); repeat revascularization (Panel C); and the composite primary end point of major adverse cardiac or cerebrovascular events (Panel D). The two groups had similar rates of death from any cause (relative risk with PCI vs. CABG, 1.24; 95% confidence interval [CI], 0.78–1.98) and rates of death from any cause, stroke, or MI (relative risk with PCI vs. CABG, 1.00; 95% CI, 0.72–1.38). In contrast, the rate of repeat revascularization was significantly increased with PCI (relative risk, 2.29; 95% CI, 1.67–3.14), as was the overall rate of major adverse cardiac or cerebrovascular events (relative risk, 1.44; 95% CI, 1.15–1.81). The I bars indicate 1.5 SE. Relative risks were calculated from the binary rates. P values were calculated with the use of the chi-square test